Myeloma UK Chief Executive, Eric Low, speaks about the u-turn by NICE on myeloma drug Velcade -- a move which looks set to approve use of the drug on the NHS after being turned down in 2006
In this interview on BBC Breakfast News on 4 June, myeloma patient, Jacky Pickles, one of the Velcade 3 discusses the potential impact of the recent NICE announcement on Velcade.